Targacept News
Most Popular Targacept Story
AstraZeneca outlines pricey licensing strategy
AstraZeneca faces a critical challenge in gaining new approvals ahead of the patent cliff that's looming for some of its biggest revenue generators. And AZ's business development chief tells Read more...
Latest Headlines
- January 5, 2012
- December 19, 2011
- November 8, 2011
- October 14, 2011
- July 12, 2011
- March 24, 2011
- March 4, 2011
- January 19, 2011
- January 11, 2010
- December 10, 2009
- December 3, 2009
- August 4, 2009
- July 15, 2009
- July 8, 2009
- March 11, 2009
- December 9, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
